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Interleukin (IL)-7 is a cytokine essential for T lymphocyte development and homeostasis. 
However, little is known about the roles of IL-7 receptor α-chain (IL-7Rα) in late stages of T 
cell development. To address this question, we established IL-7Rα-floxed mice and crossed 
them with CD4-Cre transgenic mice. Resultant IL-7R conditional knockout (IL-7RcKO) mice 
exhibited marked reduction in CD8 single positive (SP) T cells, regulatory T cells (Tregs) and 
natural killer T (NKT) cells in thymus. The proportion and proliferation of both mature 
CD4SP and CD8SP thymocytes were decreased without affecting Runx expression. In 
addition, expression of the glucocorticoid-induced TNF receptor (GITR) was reduced in 
CD4SP and CD8SP thymocytes, and expression of CD5 was decreased in CD8SP thymocytes. 
IL-7RcKO mice also showed impaired Treg and NKT cell proliferation and inhibition of 
NKT cell maturation. Bcl-2 expression was reduced in CD4SP and CD8SP thymocytes but 
not in Tregs and NKT cells, and introduction of a Bcl-2 transgene rescued frequency and CD5 
expression of CD8SP thymocytes. Furthermore, IL-7RcKO mice exhibited greatly increased 
numbers of B cells and, to a lesser extent, of γδ T and dendritic cells in thymus. Overall, this 
study demonstrates that IL-7Rα differentially controls development and maturation of 
thymocyte subpopulations in late developmental stages and suggests that IL-7R expression on 





Interkeukin (IL)-7 is a cytokine essential for lymphocyte development and survival. The IL-7 
receptor (IL-7R) consists of a common cytokine receptor γ-chain (γc) and a unique IL-7R 
α-chain (IL-7Rα). IL-7Rα also forms the receptor for thymic stromal lymphopoietin (TSLP) 
by interacting with the TSLP receptor. Mice deficient in either IL-7 or IL-7Rα show 
markedly reduced numbers of T and B cells. The IL-7R transmits signals for proliferation and 
survival and for V(D)J recombination of immunoglobulin heavy chain and T cell receptor 
(TCR) γ-chain loci in early lymphocytes (1, 2). In the periphery, IL-7 regulates T cell 
homeostasis by enhancing survival and proliferation of naive and memory T cells (3). Upon 
IL-7 binding, the IL-7R activates JAK1 and JAK3 tyrosine kinases, which then activates 
STAT5 and phosphatidylinositol 3-kinase. IL-7 signaling promotes cell survival by inducing 
expression of anti-apoptotic factors such as Bcl-2, Bcl-xL and Mcl-1 in T cells (4). Thus, 
introduction of Bcl-2 transgenes significantly rescues T cell development in IL-7Rα-deficient 
mice (5, 6). 
  The γc cytokine signal controls differentiation of CD8 single positive (SP) 
thymocytes. The IL-7R is expressed on CD4-8- double negative (DN) thymocytes but then 
down-regulated in CD4+8+ double positive (DP) thymocytes. After positive selection, 
transient cessation of TCR signaling induces IL-7Rα re-expression on post-selection 
thymocytes (7). The IL-7R permits thymocytes to differentiate into the CD8 lineage (8). Both 
Runx3 and STAT transcription factors function in CD8 T cell differentiation by interacting 
with CD8 enhancer, which is responsive to IL-7 (7). In contrast, other group reported that 
CD8 lineage specification occurs normally in the absence of IL-7R signaling by anti-IL-7R 
antibody (9). In addition, IL-15 also functions in CD8 T cell differentiation (10). However, 
little is known about precise roles of the IL-7R in CD8 T cell development, since 
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IL-7Rα-deficient mice show severely impaired expansion of DN thymocytes.  
 The roles of the IL-7R in development of regulatory T cells (Tregs) and natural 
killer T (NKT) cells remain controversial. In γc-deficient mice, Tregs are severely reduced in 
the thymus (11-13). Although the proportion of Tregs to non-Treg CD4 T cells is not altered 
in the IL-7Rα-deficient thymus, IL-7Rα/IL-2Rβ doubly deficient mice show more severe 
reduction of Tregs than do IL-2Rβ-deficient mice, and the absolute number of Tregs is 
reduced in IL-7Rα-deficient mice (11-14). As for NKT cell development, it is reported that 
γc-deficient mice lack thymic NKT cells (15). In contrast, the proportion of NKT cells is not 
reduced in the IL-7- or IL-7Rα-deficient thymus, although absolute numbers of thymic NKT 
cells are drastically reduced (15, 16). The observation that IL-7/IL-15 doubly deficient mice 
show more severe reduction in NKT cells than do IL-15-deficient mice (16). Nonetheless, the 
roles of the IL-7R in development of Tregs and NKT cells in the thymus remain unclear. 
 Early thymocyte development is severely impaired in IL-7Rα-deficient mice, 
making it difficult to precisely determine IL-7Rα function in late stages of T cell development. 
To address this question, we used a conditional knockout approach and show that IL-7Rα 





Generation of IL-7RcKO mice 
To investigate the roles of the IL-7R in the late stages of T cell development, we generated 
IL-7Rα-floxed (IL-7Rαf/f) mice (Fig. S1A and B) and bred them with CD4-Cre transgenic 
(Tg) mice (IL-7RcKO). IL-7Rα expression on DN thymocytes of IL-7RcKO mice was 
comparable with that seen in control mice (Fig. S1C). Although IL-7Rα is down-regulated on 
DP thymocytes, re-expression of IL-7Rα on CD4SP, CD8SP, Treg and NKT cells did not 
occur and IL-7R on γδ T cells was not changed in IL-7RcKO mice (Fig. S1C). Therefore, we 
conclude that CD4-Cre transgene-mediated deletion of the IL-7Rα gene was successfully 
achieved. 
 
IL-7R is required for development of CD8 T cells in thymus 
First, we compared the total cell number of thymocytes between IL-7RcKO and littermate 
control mice. Unexpectedly, thymocyte number was slightly increased in IL-7RcKO mice 
(control: 212 ± 7.1 x 106 versus IL-7RcKO: 241 ± 8.4 x 106) (Fig. 1A). IL-7RcKO mice 
exhibited an almost normal proportion of DP, CD4SP and CD8SP thymocytes, while the 
proportion and absolute number of DN thymocytes increased by two-fold (Fig. 1 B and C). 
The proportion and absolute number of TCRβhigh (TCRβhi) thymocytes was reduced by 30% 
in IL-7RcKO mice (Fig. S2A). Gating on TCRβhi thymocytes revealed that the frequency of 
CD8SP thymocytes was reduced (Fig. 1D). Similar results were obtained by analyzing 
IL-7RcKO mice crossed with OT-I and H-Y TCR Tg mice, whereas the frequency of CD4SP 
thymocytes was unchanged in IL-7RcKO mice crossed with OT-II TCR Tg mice (Fig. S2B). 
The absolute number of TCRβhi CD8SP and CD4SP thymocytes decreased by 40% and 10%, 
respectively, in IL-7RcKO mice (Fig. 1C). Consistent with previous reports that γc cytokines 
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influence CD8 T cell commitment (8), our results confirm that IL-7 is not the only factor that 
regulates development of CD8SP thymocytes. Our data also suggest that the IL-7R is required 
for CD4SP thymocytes, although to a lesser extent. 
 
IL-7R controls proliferation of mature CD4SP and CD8SP thymocytes 
During positive selection, thymocytes undergo progressive stages of development from 
TCRβintermediate(TCRβint)CD69+ to TCRβhiCD69+. After positive selection, SP thymocytes first 
acquire a semi-mature phenotype (CD69+HSAhiQa-2lowCD62Llow) and then differentiate into 
mature phenotype (CD69-HSAlowQa-2hiCD62Lhi). While the IL-7R is down-regulated in most 
of DP thymocytes, its re-expression begins in TCRβintCD69+ DP cells (17). Although the 
frequency of TCRβintCD69+ cells was unchanged in IL-7RcKO mice, the frequency of 
TCRβhiCD69- and TCRβhiHSAlow cells were more severely reduced than were TCRβhiCD69+ 
and TCRβhiHSAhi cells in IL-7RcKO mice (Fig. 2A and Fig. S3A). Compared with control 
mice, thymocytes with HSAlowQa-2hi and HSAlowCD62Lhi mature phenotypes were decreased 
in both CD4SP and CD8SP thymocytes in IL-7RcKO mice (Fig. 2B and Fig. S3B). These 
results demonstrate that generation of both mature CD4SP and CD8SP thymocytes is 
impaired in IL-7RcKO mice. 
 Because mature thymocytes reportedly proliferate in the thymus (18), we performed 
BrdU incorporation assay. Twenty-four hours after injection, the frequency of BrdU+ cells 
was reduced by 2- to 3-fold in TCRβhiHSAlow CD4SP and CD8SP thymocytes of IL-7RcKO 
compared to control mice, although some proliferation still occurred without IL-7R signaling 
(Fig. 2C). We obtained similar results even 4 hours after a BrdU pulse (Fig. S3C). Consistent 
with a previous observation (19), these results demonstrate that the IL-7R drives mature SP 
thymocytes to proliferate in the thymus but that other signals also regulate CD4SP and 
CD8SP thymocytes. 
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 To determine the role of the IL-7R in acquiring functional competence by SP 
thymocytes, we analyzed expression of genes characteristic for each population. Transcripts 
of Runx1 and GATA3, CD4SP-enriched transcription factors, in TCRβhiCD4SP thymocytes 
were comparable between control and IL-7RcKO mice (Fig. S3D). Next we measured 
CD8SP-enriched mRNAs encoding perforin-1, granzyme B and Eomes. There was not 
statistically significant difference between control and IL-7RcKO mice (Fig. 2D). Although it 
was reported that IL-7 signaling induces Runx3 transcription in post-selected DP thymocytes 
in vitro (8), Runx3 was not changed in TCRβhiCD8SP thymocytes of IL-7RcKO mice (Fig. 
2D).  
 IL-7 signaling reportedly regulates CD8α co-receptor expression (20). In 
IL-7RcKO mice, CD8α expression on TCRβhiCD8SP thymocytes was marginally decreased 
and was not changed in peripheral CD8 T cells (Fig. 2E and S3E). Gating on TCRβhiHSAhi, 
but not TCRβhiHSAlow, thymocytes (including 4SP, DP and 8SP) revealed that CD8α 
expression on CD8α+ population was significantly reduced in IL-7RcKO mice (Fig. S3F). We 
also found that a co-stimulatory molecule, the glucocorticoid-induced TNF receptor (GITR), 
was slightly reduced especially in TCRβhi CD4SP thymocytes and peripheral CD4T cells of 
IL-7RcKO mice (Fig. 2F and S3G). Furthermore, CD5 expression on CD8SP thymocytes was 
lower in IL-7RcKO compared to control mice, whereas that on CD4SP thymocytes was 
unchanged (Fig. 2G). These results suggest that the IL-7R plays some role in quality control 
of both CD4SP and CD8SP thymocytes. 
 
Bcl-2 expression rescues development and CD5 expression of CD8SP thymocyte 
Enforced expression of Bcl-2 reportedly promotes significant recovery of thymic T cells in 
IL-7Rα-deficient mice (5, 6), indicating that the IL-7R primarily serves a survival signal. 
Therefore, we compared Bcl-2 expression in thymocyte subpopulations between control and 
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IL-7RcKO mice. Like IL-7Rα expression, Bcl-2 levels were almost comparable in DN and 
DP thymocytes but were significantly reduced in CD4SP and CD8SP thymocytes in 
IL-7RcKO mice (Fig. 3A). Furthermore, IL-7RcKO thymocytes showed higher caspase-3 
activity than control mice with or without IL-7 in vitro (Fig. S4A). In contrast, Bcl-xL and 
Mcl-1 were unchanged (Fig. S4 B and C).  
 To test whether Bcl-2 expression rescues SP thymocyte development in IL-7RcKO 
mice, we bred IL-7RcKO mice with Bcl-2 Tg mice. Introduction of the Bcl-2 transgene 
completely restored the frequency of TCRβhi thymocytes in IL-7RcKO mice (Fig. 3B). 
Furthermore, the ratio of CD8SP to CD4SP thymocytes and absolute cell number of CD8SP 
thymocytes were also recovered in IL-7RcKO mice harboring the Bcl-2 transgene, although 
they did not reach to those of Bcl-2 Tg mice (Fig. 3B and S4D). In addition, introduction of 
the Bcl-2 transgene also restored CD5 expression on CD8SP thymocytes in IL-7RcKO mice 
(Fig. 3C), although Bcl-2 misexpression in control mice did not affect CD5 level on 
TCRβhiCD8SP thymocytes (Fig. S4E). These results suggest that the IL-7R transmits a 
survival signal for CD8SP thymocytes primarily through Bcl-2 and that reduced CD5 
expression in IL-7RcKO mice may be attributable to reduced survival. 
 
IL-7R promotes Treg proliferation in the thymus 
Although γc signaling is critical for thymic Treg development, it is unclear whether IL-7Rα 
functions in this process. To address this question, we analyzed development of thymic Tregs 
in IL-7RcKO mice. The frequency and absolute number of both CD25- and CD25+ Foxp3+ 
cells were decreased by 20% in TCRβhiCD4SP thymocytes of IL-7RcKO mice (Fig. 4 A and 
B). Because some Tregs develop from DP thymocytes in the medulla (21), we also examined 
Tregs in the TCRβhiDP fraction. The frequency and absolute number of Foxp3+ cells were 
also reduced by 30% in TCRβhiDP cells (Fig. 4 A and B). These results suggest that the IL-7R 
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participates in thymic Treg development. 
 Next we analyzed the basis of Treg reduction in IL-7RcKO mice. Bcl-2 expression 
in Foxp3+ 4SP and DP thymocytes was comparable between control and IL-7RcKO mice  
(Fig. 4C, top). Bcl-xL expression was also unchanged (Fig. 4C, bottom). Introduction of the 
Bcl-2 transgene appeared to rescue the frequency of Foxp3+ CD4SP thymocytes in IL-7RcKO 
mice (Fig. S5A). However, CD4SP thymocytes of Bcl-2 Tg mice contain more Foxp3+ cells 
compared with control mice, and the frequency of Foxp3+ cells in IL-7RcKO x Bcl-2 Tg mice 
did not reach the levels seen in Bcl-2 Tg mice (Fig. S5A). These results suggest that factors 
downstream of the IL-7R other than survival signals regulate Treg development. On the other 
hand, the frequency of BrdU+ cells was reduced in Tregs of IL-7RcKO mice (Fig. 4D). The 
co-stimulatory molecules CTLA-4 and GITR are reportedly constitutively expressed on Tregs 
and regulate their activity (22). However, expression of intracellular CTLA-4 and surface 
GITR was unchanged in Tregs of IL-7RcKO mice (Fig. S5B). Overall, these results suggest 
that the IL-7R is required for proliferation but not essential for functional maturation of 
thymic Tregs. 
 
IL-7R promotes proliferation and maturation of invariant NKT (iNKT) cells in thymus 
iNKT cells are derived from DP thymocytes through interaction of invariant Vα14-Jα18 
TCRα chain with CD1d expressed on DP thymocytes. Although the proportion of iNKT cells 
was not reduced in IL-7- or IL-7Rα-deficient thymus (15, 16), it is unclear whether the IL-7R 
participates in NKT cell development. To address this question, we analyzed IL-7RcKO 
thymocytes by using CD1d-tetramer loaded with α-GalCer. The frequency of CD1d-tetramer+ 
iNKT cells was reduced 2-fold in IL-7RcKO compared to control mice (Fig. 5A). After 
selection, iNKT cells begin to mature from stage 0 (HSA+) and then proceed to stage 1 
(CD44-NK1.1-), stage 2 (CD44+NK1.1-) and stage 3 (CD44+NK1.1+) (23). We found that 
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frequency of stage 3 iNKT cells was reduced in IL-7RcKO mice (Fig. 5B). Absolute numbers 
of iNKT cells were decreased in IL-7RcKO mice by 30%, 45% and 50% in stages 0/1, 2 and 
3, respectively, suggesting that iNKT cell maturation is partially blocked (Fig. 5C). iNKT 
cells reportedly differentiate primarily into CD4+ NKT cells and to a lesser extent into DN 
NKT cells. DN iNKT arise from CD4+ precursors before stage 3 and DN and CD4+ iNKT 
cells are suggested to be functionally different (24, 25). In IL-7RcKO mice, frequency of DN 
iNKT cells was reduced compared to control mice (Fig. 5D), suggesting that differentiation or 
survival of DN iNKT cells depends on IL-7R signaling more than CD4+ NKT cells. Similar 
results were also observed in peripheral tissue (Fig. S6A). These results demonstrate that 
IL-7R signaling is required for iNKT cell maturation after the DP stage. 
 To determine the mechanism underlying reduction of iNKT cells in IL-7RcKO 
mice, we first checked expression of anti-apoptotic factors. Bcl-2 and Bcl-xL expression in 
iNKT cells was comparable between control and IL-7RcKO mice (Fig. 5E). In contrast to 
CD8SP thymocytes and Tregs, introduction of the Bcl-2 transgene did not rescue the 
frequency of iNKT cells in IL-7RcKO mice (Fig. S6B). Since iNKT cells rapidly proliferate 
after selection (26), we next analyzed proliferation. Twenty-four hours after BrdU injection, 
BrdU+ iNKT cells were greatly decreased in IL-7RcKO compared with control mice (Fig. 5F). 
These results suggest that the IL-7R is important for proliferation of thymic iNKT cells. 
 
IL-7RcKO mice show increased numbers of γδ T cells, B cells and dendritic cells (DCs) 
in thymus 
The frequency and absolute number of DN thymocytes increased 2-fold in IL-7RcKO mice 
(Fig. 1 B and C). To define what cell type had increased, we first checked γδ T cells. Both 
frequency and absolute number of γδ T cells were increased in IL-7RcKO thymus by 1.5-fold 
(Fig. 6A). In addition, we found that NK1.1+ γδ T cells were increased in IL-7RcKO thymus 
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(Fig. S7A). By contrast, the absolute number of CD3-NK1.1+ NK cells was comparable (Fig. 
S7B). 
 Although γδ T cells were increased, it did not account for the overall increase of DN 
thymocytes in IL-7RcKO mice (Fig. 1C). Therefore, we assessed CD3-CD4-CD8- triple 
negative thymocytes based on CD25 and CD44 expression. Interestingly, the frequency of 
DN1 (CD25-CD44+) cells was 3-fold higher in IL-7RcKO mice (Fig. 6B). Next, we analyzed 
the expression of several lineage markers and found that the frequency of B220+ cells 
increased by 2- to 3-fold (Fig. 6C). The absolute number of B220+ DN1 cells increased by 
20-fold in IL-7RcKO mice. These cells were confirmed to be B lineage cells, because they 
expressed both MHC class II and CD19 (Fig. S7C), and about 30% of the B220+CD19+ cells 
were surface IgM+ (Fig. S7D). The absolute number of CD11c+ cells in the DN1 fraction also 
increased in IL-7RcKO mice (Fig. 6C). In total thymocytes, the frequency and absolute 
number of CD11c+B220+ plasmacytoid DCs (pDC) increased by 2-fold in IL-7RcKO thymus, 
while the numbers of CD11c+B220- conventional DCs (cDC) did not show a statistically 
significant difference (Fig. 6D and 6E). 
 To examine the mechanism underlying the increase in γδ T cells, B cells and DCs in 
IL-7RcKO thymus, we analyzed proliferation. Twenty-four hours after BrdU injection, we 
detected a greater number of BrdU+ B cells in IL-7RcKO than in control mice (Fig. 6F). In 
contrast, the frequency of BrdU+ cells in γδ T cells and plasmacytoid DCs was unchanged in 
IL-7RcKO mice at 24 hour after injection (Fig. S7E). These results suggest that IL-7R 




The IL-7R may influence negative selection of CD8SP thymocytes, because the IL-7R 
transmits survival signal in CD8SP thymocytes. CD5 expression correlates positively with the 
strength of TCR signal during positive selection (27). IL-7R signaling may be required for 
resistance against negative selection via Bcl-2 induction. In IL-7RcKO mice, negative 
selection might be enhanced, deleting CD8SP thymocytes receiving a relatively strong TCR 
signal, which normally results in survival. Actually, introduction of the Bcl-2 transgene in 
IL-7RcKO mice restored CD5 expression on CD8SP thymocytes (Fig. 3C). Another 
possibility is that reduced CD8α expression in IL-7RcKO mice might have attenuated TCR 
signaling by co-receptor tuning (20), which results in lower CD5 expression. In contrast to 
our results, it was reported that IL-7R signaling does not play a role in post-selection 
thymocytes (9). Although the reason for the discrepancy is not clear, it might be that the 
blocking of IL-7R signaling by antibody was not complete. 
 The IL-7R may also function in development of conventional CD4 T cells (Fig. 1C). 
Bcl-2 expression and BrdU incorporation were severely reduced in CD4SP thymocytes. This 
is mainly attributable to conventional CD4SP cells, since Bcl-2 levels were unchanged in 
Tregs and NKT cells, and BrdU+CD4SP excluding Foxp3+ and CD1d-tetramer+ cells were 
still reduced in IL-7RcKO mice (Fig. S8A). Therefore, our study suggests that the IL-7R 
likely plays multiple roles in proliferation, survival and maturation during conventional CD4 
T cell development. 
 The molecular link between the IL-7R and thymocyte proliferation is still unclear. 
Degradation of p27Kip1 by its phosphorylation is important for IL-7-induced proliferation (28). 
The IL-7R induces the transcription of pim-1 (29), and pim-1 can phosphorylate p27Kip1 (30). 
However, expression of pim-1 was unchanged in SP thymocytes of IL-7RcKO mice (Fig. 
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S8B). In another possibility, like IL-2, the IL-7R activates Akt, which phosphorylates 
Forkhead transcription factors and inhibits the transcription of p27Kip1 gene (31). However, 
p27Kip1 mRNA was not increased in IL-7RcKO mice (Fig. S8B). Because Akt can directly 
phosphorylates p27Kip1 (32), p27Kip1 degradation mediated directly by Akt might be 
responsible for IL-7-induced proliferation. 
 The role of the IL-7R in Treg development has been a matter of debate. Previous 
studies with IL-7Rα-deficient mice led to varying conclusions (11-14). In this study, we 
found that IL-7R is partially responsible for intrathymic Treg proliferation (Fig. 4D). Bcl-2 
misexpression rescued Tregs in IL-7RcKO mice (Fig. S5A). However, alteration in cell 
survival might not be the major reason for reduced Treg number, since Bcl-2 and Bcl-xL 
expression was unchanged in IL-7RcKO mice and the frequency of Tregs in IL-7RcKO mice 
harboring a Bcl-2 transgene did not reached the levels seen in Bcl-2 Tg mice (Fig. 4C and 
S5A). We hypothesize that the increased number of Foxp3+ cells in Bcl-2 Tg mice are 
progeny that escape negative selection and that Tregs are not in fact rescued in IL-7RcKO 
mice carrying the Bcl-2 transgene. The second possibility is that Tregs with lower Bcl-2 
expression did not survive in IL-7RcKO mice and that the remaining cells were those with 
Bcl-2 levels that had reached a certain threshold. 
 The IL-7R appears to play multiple roles in NKT cell development. IL-7RcKO 
mice showed markedly reduced numbers of thymic iNKT cells with impaired proliferation 
(Fig. 5 C and F). The IL-7R seems not to be essential for NKT cell survival, because Bcl-2 
and Bcl-xL expression was unchanged in NKT cells and Bcl-2 misexpression in IL-7RcKO 
mice did not rescue iNKT cells (Fig. 5E and Fig. S6B). Because Bcl-xL, but not Bcl-2, 
reportedly rescues iNKT cell development in IL-15-/- mice (33), it is possible that iNKT cells 
with lower Bcl-xL expression did not survive in IL-7RcKO mice and that the remaining cells 
were those with Bcl-xL levels that had reached a certain threshold by receiving IL-15 signal. 
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 B cell development in the thymus is influenced by several factors. For example, 
TCRβ-deficient mice show a 10-fold increase in the number of thymic B cells (34), 
suggesting that disrupting αβ T cell development alone is sufficient to increase the number of 
thymic B cells. In the IL-7RcKO thymus, B cells were increased 20-fold (Fig. 6C). Although 
less prominent than B cells, γδ T cells and DCs were also increased in the IL-7RcKO thymus 
(Fig. 6 A, C and E). γδ T cells, some immature B cells and pDCs express IL-7R both in 
control and IL-7RcKO mice (Fig. S1C and S7F). IL-7R expression in pDCs was slightly 
reduced in IL-7RcKO mice, as previously suggested that CD4-Cre mice partially deletes 
floxed allele in CD11c+ cells (35). IL-7 concentrations may be higher in and around the 
medulla of IL-7RcKO thymus than control thymus, because SP thymocytes do not consume 
IL-7 produced by thymic epithelial cells. Therefore, we suggest that suppression of B cell 
development in thymus requires adequate IL-7 concentrations in addition to T cell 
specification via Notch signaling. This is in agreement with recent report that over-expression 
of IL-7 promotes extensive B cell development in the thymus (36). TSLP concentrations 
might also contribute to this mechanism. 
 Although not analyzed mainly, peripheral T cells of IL-7RcKO mice showed 
several characteristics as expected from previous studies. First, peripheral T cell numbers 
were greatly reduced in IL-7RcKO mice (Fig. S9 A-G). Lymphopenia-induced proliferation 
was also impaired in T cells (Fig. S9H). As previously reported in IL-7R-/- mice (37, 38), 
TCR-induced proliferation was also reduced in IL-7RcKO mice (Fig. S9I), although TCR 
expression and early activation, as monitored by CD69 expression, were normal (Fig. S9 J 
and K). This result suggests that IL-7R is required for expansion of effecter T cells, that is, 
generation of memory T cell precursors. Suppressive activity of Treg from IL-7RcKO mice 
was also diminished (Fig. S9L), as previously reported in IL-7R-/- mice (13). 
 In summary, we characterized roles of the IL-7R in survival, proliferation and 
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maturation of different subpopulations of αβ thymocytes. These findings will accelerate the 
understanding of IL-7R function in thymus and the periphery, and IL-7Rα-floxed mice should 
serve as a powerful tool to determine the mechanism underlying how the IL-7R controls T 
cell development and immune responses.
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Materials and Methods 
 
Mice. 
Generation of IL-7Rα-floxed mice is described in SI Materials and Methods. CD4-Cre Tg 
mice were reported previously (39). H2K-Bcl-2 Tg mice were described previously (40). All 
mice were analyzed at 4-5 weeks of age. Control (IL-7R+/+ CD4-Cre or IL-7Rfl/fl) and 
IL-7RcKO (IL-7Rfl/fl CD4-Cre) mice were compared. All mice were maintained under 
specific pathogen-free conditions at the Experimental Research Center for Infectious Diseases 
at the Institute for Virus Research, Kyoto University. All mouse protocols were approved by 
Kyoto University.  
 
Antibodies and Flow Cytometry. 
The fluorescent dye- or biotin-conjugated antibodies used in this study were described in SI 
Materials and Methods. Intracellular staining was performed using a Foxp3 staining buffer set 
(eBioscience) or Cytofix/Cytoperm (BD Biosciences) according to the manufacturer’s 
instruction. Stained cells were analyzed with a FACSCalibur or FACSCanto II flow 
cytometer (BD Biosciences). Data were analyzed using FlowJo software (Tree Star). Values 
in quadrants, gated area and interval gates indicate the percentages in each population in all 
figures. Cell sorting was performed using a FACSAria II cell sorter (BD Biosciences). 
 
Real-time RT-PCR. 
Total RNA was isolated and treated with RNase-free DNase to remove genomic DNA. After 
DNase inactivation, total RNA was reverse-transcribed with random primer. cDNA was 
amplified by using an ABI 7500 Sequence Detector (Applied Biosystems) with QuantiTect 
SYBR Green PCR Kit (QIAGEN) with ROX reference dye (Invitrogen). PCR was carried out 
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at 95°C for 15 min, followed by 40 cycles consisting of 95°C for 20 s, 55°C for 30 s and 72°C 
for 60 s. PCR efficiency was normalized using cDNA of whole thymocytes from wild-type 
mice. Primer sequences are listed in SI Materials and Methods. 
 
BrdU Incorporation Assay. 
Mice were injected intraperitoneally with 1 mg of BrdU (Sigma-Aldrich). Four or twenty-four 
hours after injection, thymocytes were stained with surface markers, fixed and permeabilized 
with Cytofix/Cytoperm, and treated with DNase at 37°C for 1 h. BrdU was stained with a 
FITC-conjugated anti-BrdU antibody (BD Biosciences). Values in histogram indicate the 
percentages of BrdU+ cells defined by interval gates. 
 
Flow Cytometry for DCs. 
The thymus was cut into small pieces and digested with 1.25 mg/ml collagenase D (Roche) 
and 0.01% DNase I (Roche) in RPMI 1640 medium for 30 min at 37°C. The cell suspension 
was gently passed through 24-gauge needles twice, washed twice and used for staining. 
 
Statistics. 
An unpaired two-tailed Student t test was used for all of the statistical analysis. Asterisks in 
all figures indicate as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.005; ****, p < 0.001. n.s. 
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Figure 1. IL-7R is required for development of CD8 T cells in thymus. 
(A) Absolute numbers of thymocytes from control (IL-7R+/+ CD4-Cre or IL-7Rfl/fl) and 
IL-7RcKO (IL-7Rfl/fl CD4-Cre) mice of 4-5 weeks old. Cell numbers from individual mice 
(circles) and means (horizontal bars) are shown (n = 35). (B) CD4 and CD8 expression in 
total thymocytes. (C) Absolute numbers of indicated populations (mean ± SEM, n = 35). (D) 
Expression of CD4 and CD8 in thymocytes gated on TCRβhi cells. Representative data are 
shown (n > 10) (B and D). 
 
Figure 2. IL-7R controls proliferation of mature CD4SP and CD8SP thymocytes. 
(A) Expression of TCRβ and CD69 in thymocytes. (B) Expression of HSA and Qa-2 in 
TCRβhiCD4SP excluding CD4+CD8low and TCRβhiCD8SP thymocytes. (C) BrdU uptake by 
TCRβhiHSAlow CD4SP and CD8SP thymocytes. Data represent four independent experiments 
with similar results. (D) Real-time RT-PCR analysis showing expression of indicated genes in 
TCRβhiCD8SP thymocytes from control (open bars) and IL-7RcKO (filled bars) mice. 
Transcripts levels were normalized to hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) mRNA. Values are the mean ± SEM of triplicate data points from three to six 
independent experiments. (E) CD8α expression on TCRβhiCD8SP thymocytes.  
Representative data and mean fluorescence intensity (MFI) are shown (n > 10). (F-G), GITR 
(F) and CD5 (G) expression on TCRβhiCD4SP and TCRβhiCD8SP thymocytes. Data 
represent five independent experiments with similar results. 
 
Figure 3. IL-7R transmits survival signals in CD8SP thymocytes through Bcl-2. 
(A) Expression of Bcl-2 in thymocyte fractions. 4SP and 8SP indicate 
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TCRβhiCD25-Foxp3-CD4SP and TCRβhiCD8SP, respectively. Data represent five 
independent experiments with similar results. (B) Histograms (top) indicate expression of 
TCRβ in total thymocytes from mice of each genotype. Dot plots (bottom) show CD4 and 
CD8 expression in TCRβhi thymocytes. Bar graph (right) shows the ratio of CD8SP to 
CD4SP cells in TCRβhi thymocytes (mean ± SEM, n = 8-11). (C) CD5 expression in 
TCRβhiCD8SP thymocytes from indicated mice. Data represent four independent experiments 
with similar results. 
 
Figure 4. IL-7R promotes Treg proliferation in thymus. 
(A) Expression of Foxp3 and CD25 in TCRβhiCD4SP and TCRβhiDP thymocytes. Data 
represent eight independent experiments with similar results. (B) Absolute numbers of Foxp3+ 
cells in CD4SP and DP thymocytes (mean ± SEM, n = 8). (C) Bcl-2 and Bcl-xL expression in 
Foxp3+TCRβhi CD4SP (left panels) and Foxp3+TCRβhi DP (right panels) thymocytes. Data 
represent five (Bcl-2) and two (Bcl-xL) independent experiments with similar results. (D) 
BrdU incorporation in Foxp3+TCRβhi CD4SP Tregs. BrdU was injected 24 h before analysis. 
Data represent three independent experiments with similar results. 
 
Figure 5. IL-7R promotes proliferation and maturation of thymic iNKT cells. 
(A) TCRβ and CD1d tetramer (CD1d-tet) expression in total thymocytes. Representative data 
are shown (n = 12). (B) Expression of CD44 and NK1.1 in TCRβ+CD1d-tet+ thymocytes. 
Representative data are shown (n = 11). (C) Absolute numbers of TCRβ+CD1d-tet+ 
thymocytes in stage 0/1, stage 2 and stage 3. Cell numbers were calculated based on flow 
cytometry data in (A) and (B) (mean ± SEM, n = 11). (D) Expression of CD4 and CD8 in 
TCRβ+CD1d-tet+ thymocytes. Data represent of eight independent experiments with similar 
results. (E) Bcl-2 and Bcl-xL expression in TCRβhiCD1d-tet+ thymocytes. Data represent three 
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(Bcl-2) and two (Bcl-xL) independent experiments with similar results. (F) BrdU 
incorporation by TCRβ+CD1d-tet+ thymocytes 24 h after the pulse. Data represent three 
independent experiments with similar results. 
 
Figure 6. IL-7RcKO mice show increased numbers of γδ  T cells, B cells and DCs in 
thymus.  
(A) Dot plots (left) show CD3 and γδTCR expression in thymocytes. Bar graph (right) 
indicates the absolute numbers of CD3+γδTCR+ cells (mean ± SEM, n = 14). (B) Expression 
of CD44 and CD25 in CD3-CD4-CD8- thymocytes. Representative data are shown (n = 11). 
(C) Expression of CD11b, CD11c, B220 and NK1.1 in CD3-CD4-CD8-CD44+CD25- DN1 
cells was analyzed by flow cytometry. Percentages (left) and absolute cell numbers (right) of 
each marker positive population are shown (mean ± SEM, n = 7). (D) B220 and CD11c 
expression of thymocytes isolated with collagenase. Data represent six independent 
experiments with similar results. (E) Absolute numbers cDC (B220-CD11c+) and pDC 
(B220+CD11c+) (mean ± SEM, n = 6). (F) BrdU incorporation by B220+CD11c- B lineage 
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SI Materials and Methods 
 
Generation of IL-7Rα-floxed Mice. 
The targeting vector was constructed by Red recombination technology with a murine BAC 
clone containing the IL-7Rα locus (RP23-267M6). One loxP sequence was inserted 97-bp 
downstream of IL-7Rα exon 2 and the neomycin resistance gene cassette flanked by FRT 
sequences on both sides and one loxP sequence at the 5’ end was inserted 288-bp upstream of 
exon 2 (Fig. S1A). The targeting vector was isolated with the 2.2-kb 5’-homologous fragment, 
a neomycin resistance gene cassette, and a 5.6-kb 3’-homologous fragment, flanked by 
diphtheria toxin A subunit cDNA. The linearized targeting vector was introduced into the 
KY1.1 embryonic stem (ES) cell line. Homologous recombinants were screened by PCR and 
confirmed by Southern blot analysis with 5’ and 3’ probes (Fig. S1B). The neomycin 
resistance gene cassette was removed from the recombinant allele by infecting targeted ES 
clones in vitro with the adenovirus expressing Flp recombinase, AxCAFLP (1). 
IL-7Rα-floxed mice obtained were backcrossed into C57BL/6 mice 6 to 9 times. 
 
Antibodies for Flow Cytometry. 
The following fluorescent dye- or biotin-conjugated antibodies were used: CD3 (145-2C11), 
CD4 (GK1.5 or RM4-5), CD8 (53-6.7), TCRβ (H57-597), γδTCR (GL-3), CD11c (N418), 
CD25 (PC61.5), Qa-2 (69H1-9-9), CD62L (MEL-14), MHC class II (M5/114.15.2), CD19 
(MB19-1), BP1 (6C3), IL-7Rα (A7R34), Foxp3 (FJK16s), rat IgG2aκ (eBR2a),  hamster IgG 
isotype control, streptavidin-PE, streptavidin-PE-Cy7, and CaspGLOW TM Fluorescein 
Active Caspase-3 Staining Kit (purchased from eBioscience); NK1.1 (PK136), CD44 (IM7), 
GITR (DTA-1), and streptavidin-allophycocyanin (purchased from BioLegend); and CD69 
(H1.2F3), Cytotoxic T-lymphocyte antigen (CTLA)-4 (UC10-4F10-11), rat IgG2bκ isotype 
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control (A95-1), anti-Mouse Bcl-2 Set, and BrdU FITC set (purchased from BD Biosciences). 
Alexa Fluor 488-conjugated anti-Bcl-xL (54H6) and rabbit IgG isotype control were kindly 
provided by Beckman Coulter, Tokyo, Japan. PE-conjugated anti-IgM was purchased from 
Southern Biotechnology. Allophycocyanin-conjugated CD1d-tetramer loaded with α-GalCer 
was purchased from ProImmune. The following antibodies were purified from hybridoma 
supernatant and fluorescent dye- or biotin-labeled: CD24 (heat stable antigen) (M1/69), B220 
(RA3-6B2), CD11b (M1/70), CD5 (53-7.3).  
 
Peripheral T Cell Isolation and Cell Culture. 
Lymph nodes (LNs) were isolated from cervical, axillary, brachial, inguinal, and mesenteric 
regions. Naive T cells were sorted from LNs and spleen as TCRβ+CD25-NK1.1-CD44lowCD4+ 
or TCRβ+CD44lowCD8+ cells by FACSAria II. Cells were cultured in RPMI 1640 medium 
supplemented with 10% (vol/vol) FCS, 50 µM 2-mercaptoethanol, and antibiotics in 5% 
(vol/vol) CO2 at 37°C. The 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl) -2-(4-sulfophenyl)-2H-tetrazolium
) (MTS) assay was performed by using CellTiter 96 AQueous One Solution Cell Proliferation 
Assay (Promega) at OD490 nm. 
 
Adoptive Transfer. 
Naive CD4 or CD8 T cells from LNs (4 x 105) and spleen (2 x 105) were mixed and labeled 
with 5 µM carboxyfluorescein diacetate succinimidyl ester (CFSE) and then intravenously 
injected to sex-matched Rag2-/- mice. 
 
Treg Suppression Assay. 
Naive CD4 and CD25+CD4 T cells were purified by FACSAria II. Naive CD4 T cells (5 x 
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104) from wild-type mice were seeded in triplicate in 96 well round bottom plate with 
erythrocytes-removed splenocytes (1 x 105) from Rag2-/- mice (used as antigen-presenting 
cells) and 0.5 µg/ml of anti-CD3. CD25+CD4 T cells from control or IL-7RcKO mice were 
added to each well at the indicated ratio. After 72 h culture, proliferation was measured by the 
MTS assay. 
 
Primer Sequences.  
Perforin-1/For, 5’-CCTATCAGGACCAGTACAAC-3’;  
Perforin-1/RV, 5’-GAGATGAGCCTGTGGTAAGC-3’;  
GranzymeB/For, 5’-TTTGTGCTGACTGCTGCTCA-3’;  
GranzymeB/RV, 5’-TCTAGTCCTCTTGGCCTTAC-3’;  
Eomes/For, 5’-GCACCAAACTGAGATGATCA-3’; 
Eomes/RV, 5’-TGCATGTTATTGTCCGCTTTGC-3’;  
Distal Runx3/For, 5’-AACAGCAGCCAACCAAGTGG-3’; 
Distal Runx3/RV, 5’-TGCTCGGGTCTCGTATGAAG-3’; 
Distal Runx1/For, 5’-ATGGCTTCAGACAGCATTTTTGAGTCATTT-3’ (2); 















1. Kondo S, et al. (2006) Efficient sequential gene regulation via FLP-and 
Cre-recombinase using adenovirus vector in mammalian cells including mouse ES 
cells. Microbiol Immunol 50:831-843. 
2. Wong WF, Kurokawa M, Satake M, Kohu K (2011) Down-regulation of Runx1 
expression by TCR signal involves an autoregulatory mechanism and contributes to 
IL-2 production. J Biol Chem 286:11110-11118. 
 31 
Supplemental Figure Legends 
 
Fig. S1. Conditional targeting of the mouse IL-7Rα  locus. 
(A) Strategy for targeting of the mouse IL-7Rα locus. B, BamHI; E, EcoRI; Neo, neomycin 
resistant cassette; DT-A, diphtheria toxin. Open boxes indicate exons. Open and filled 
triangles indicate Flp recombinase target (FRT) sequences and loxP sequences, respectively. 
Numbered filled boxes indicate probes used for Southern blot analysis. (B) Genomic DNA 
from Flp recombinase-treated ES cells were digested with BamHI and analyzed by Southern 
blotting. Probes used for detection are shown in (A). (C) IL-7R expression in thymocyte 
subpopulations. Data represent eight independent experiments. 
 
Fig. S2. Positive selection of CD8SP thymocytes is impaired in IL-7RcKO mice. 
(A) TCRβ expression in total thymocytes. Bar graphs show frequency and absolute numbers 
of TCRβhi cells in total thymocytes (n > 10). (B) CD4 and CD8 expression in CD69+ 
thymocytes from IL-7RcKO or control mice crossed with indicated transgenes on a Rag2-/- 
background. Data represent 3-4 independent experiments. 
 
Fig. S3. Mature CD4SP and CD8SP thymocytes are reduced in IL-7RcKO mice. 
(A and B) Expression of TCRβ and HSA in total thymocytes (A) and HSA and CD62L in 
TCRβhiCD4SP and TCRβhiCD8SP thymocytes (B). Data represent five independent 
experiments. (C) BrdU uptake by TCRβhiHSAlow CD4SP and CD8SP thymocytes at 4 h after 
injection. (D) Distal-Runx1 and GATA3 mRNA in TCRβhiCD4SP thymocytes. Transcripts 
levels were normalized to HPRT mRNA. Values are the mean ± SEM of triplicate data points 
from six independent experiments. (E and F) Expression of CD8α in TCRβ+CD8+ cells in 
LNs and spleen (E) and in TCRβhiHSAhi and TCRβhiHSAlow thymocytes (F). Data represent 
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more than ten experiments. (G) Expression of GITR in TCRβ+CD4+CD25- and TCRβ+CD8+ 
cells in LNs. Data represent two independent experiments. 
 
Fig. S4. Expression of anti-apoptotic factors in IL-7RcKO thymocytes. 
(A) Total thymocytes were cultured with or without 5 ng/ml IL-7 for 20 h. Active caspase-3 
expression in TCRβhiDP, TCRβhi4SP, and TCRβhi8SP thymocytes were shown. Data 
represent two independent experiments. (B) Expression of Bcl-xL in thymocytes. Data 
represent two independent experiments. (C) Mcl-1 mRNA expression in TCRβhi SP 
thymocytes. Values are the mean ± SEM of triplicate data points. Data represent three 
independent experiments. (D) Absolute number of TCRβhiCD4SP and TCRβhiCD8SP 
thymocytes from each genotype (n = 5-11). (E) CD5 expression in TCRβhiCD8SP thymocytes 
from indicated mice. Data represent three independent experiments. 
 
Fig. S5. Effect of Bcl-2 overexpression on Treg development in IL-7RcKO mice. 
(A) Expression of Foxp3 and CD25 in TCRβhiCD4SP thymocytes from indicated mice (left). 
Data represent four independent mice of each genotype. Absolute numbers of 
Foxp3+TCRβhiCD4SP Tregs from indicated genotypes (n = 4-8) (right). (B) GITR and 
intracellular CTLA-4 expression in Foxp3+TCRβhiCD4SP Tregs. Data represent three 
independent experiments.  
 
Fig. S6. Bcl-2 overexpression fails to rescue iNKT cell development in IL-7RcKO mice. 
(A) iNKT cells in spleen. Data represent two independent experiments. (B) Percentages (left) 
and absolute number (right) of iNKT cells in thymus from indicated mice (n = 3-6). 
 
Fig. S7. γδ T cells, B cells and dendritic cells are increased in IL-7RcKO mice. 
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(A) NK1.1+γδ T cells in thymus. Data represent three independent experiments. (B) Absolute 
NK cell numbers in thymus (mean ± SEM, n = 9) (C) Expression of CD19, MHC class II and 
B220 in thymocytes. Values indicate the percentages of each area. Data represent five 
independent experiments. (D) IgM expression on thymic B220+CD19+ cells. Bar graph 
indicates absolute numbers of IgM- and IgM+ thymic B cells (mean ± SEM, n = 5). (E) BrdU 
uptake by γδ T cells and pDCs in thymus at 24 h after injection. Data represent three 
independent experiments. (F) IL-7R expression on thymic B cells and pDCs. Data represent 
four independent experiments. 
 
Fig. S8. Proliferation of conventional CD4SP thymocytes is impaired in IL-7RcKO mice. 
(A) BrdU uptake by TCRβhiHSAlow CD4SP thymocytes excluding Foxp3+ and CD1d-tet+ 
cells at 24 h after injection. (B) Pim-1 and p27kip1 mRNA expression in TCRβhiSP thymocytes. 
Values are the mean ± SEM of triplicate data points. Data represent two independent 
experiments. 
 
Fig. S9. Reduced numbers and impaired functions of peripheral T cells in IL-7RcKO 
mice. 
(A) Absolute cell numbers in LNs and spleen (n = 13). (B-E) Absolute numbers of CD3+ and 
CD19+ cells (n = 5) (B), TCRβ+CD4+ and TCRβ+CD8+ cells (n = 8) (C), CD3+γδTCR+ cells 
(n = 5) (D), and TCRβ+NK1.1+ cells (n = 7) (E), in LNs and spleen. (F) Expression of Foxp3 
and CD25 in TCRβ+CD4+ cells in LNs and absolute number of Foxp3+CD4 Tregs in LNs and 
spleen (n = 7). (G) Absolute number of cDCs and pDCs in spleen (n = 5). (A-G) All mice 
were analyzed in 4-5-week-old. (mean ± SEM). (H) Naive CD4 or CD8 T cells were 
CFSE-labeled and transferred to Rag2-/- mice. Five days after transfer, donor populations 
(CD3+CD4+ or CD3+CD8+) in host Rag2-/- mice were analyzed. (I) Naive CD4 or CD8 T cells 
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(5 x 104) were cultured in 96-well plate with or without 5 µg/ml of plate-bound anti-CD3ε 
and 1 µg/ml of soluble anti-CD28. Proliferation was measured by the MTS assay after 72 h. 
Values are the mean ± SEM of duplicate data points. (J) CD3 and CD28 expression of freshly 
isolated naive T cells from LNs. (K) CD69 expression of T cells 18 h after stimulation as 
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